Mercks New Pill Cuts COVID Deaths or Hospitalizations by 50%
Merck's molnupiravir pill reduces COVID hospitalizations and deaths by 50% in clinical trials. The company plans to seek emergency FDA approval for the first oral...
Xavier University Receives $500,000 Grant for STEM Program
Xavier University of Louisiana receives exclusive $500,000 UNCF/Merck grant to expand STEM programs and increase minority representation in science fields....